Literature DB >> 8199791

5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone.

P J Cowen1, A C Power, C J Ware, I M Anderson.   

Abstract

The hypothermic, growth hormone and corticotrophin (ACTH) responses to the 5-HT1A receptor agonist buspirone (30 mg orally) were measured in 20 unmedicated patients with major depression and 20 healthy controls. Compared with the controls, the hypothermic responses of the depressed patients to buspirone were significantly attenuated, particularly in patients with melancholic depression. In contrast, the responses of growth hormone and ACTH to buspirone were unchanged. The data suggest that major depression may be associated with impaired sensitivity of 5-HT1A autoreceptors but that the function of the post-synaptic 5-HT1A receptors that mediate growth hormone and ACTH release is unaltered. Within the limitations that attend the use of buspirone as a 5-HT1A probe, our data suggest that the decrement in serotonin neurotransmission at post-synaptic 5-HT1A receptors in depression is due to decreased serotonin release rather than impaired responsivity of post-synaptic 5-HT1A receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199791     DOI: 10.1192/bjp.164.3.372

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  15 in total

1.  Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration.

Authors:  Shawn P Alter; Kristen A Stout; Kelly M Lohr; Tonya N Taylor; Kennie R Shepherd; Minzheng Wang; Thomas S Guillot; Gary W Miller
Journal:  Exp Neurol       Date:  2015-09-30       Impact factor: 5.330

2.  An increased hypothermic response to buspirone in patients with major depression.

Authors:  Ricard Navinés; Esther Gómez-Gil; Rocío Martín-Santos; María J Martínez de Osaba; Maria Luisa Imaz; Cristóbal Gastó
Journal:  Psychopharmacology (Berl)       Date:  2006-08-29       Impact factor: 4.530

Review 3.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

Review 4.  Serotonin, sex, and psychiatric illness.

Authors:  G R Heninger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 5.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

6.  Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.

Authors:  J P R Jacobsen; W B Siesser; B D Sachs; S Peterson; M J Cools; V Setola; J H A Folgering; G Flik; M G Caron
Journal:  Mol Psychiatry       Date:  2011-05-03       Impact factor: 15.992

7.  A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers.

Authors:  P de Koning; M H de Vries
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

Review 8.  The neurobiology of individual differences in complex behavioral traits.

Authors:  Ahmad R Hariri
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

9.  Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder.

Authors:  Amanda J Law; Qi Pei; Mary Walker; Helen Gordon-Andrews; Cyndi Shannon Weickert; Joram Feldon; Christopher R Pryce; Paul J Harrison
Journal:  Neuropsychopharmacology       Date:  2008-07-09       Impact factor: 7.853

Review 10.  Dietary amino acids and brain serotonin function; implications for stress-related affective changes.

Authors:  C Rob Markus
Journal:  Neuromolecular Med       Date:  2008-05-31       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.